Powered by: Motilal Oswal
04-05-2022 02:16 PM | Source: Accord Fintech
GST rate for COVID-19 medicines pegged at 5%: Pankaj Chaudhary
News By Tags | #5804 #248 #534 #1461

Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel

Union Minister of State for Finance Pankaj Chaudhary has said that COVID-19 medicines and instruments are being sold at a Goods and Services Tax (GST) rate of 5 per cent while other medicines are sold at a GST rate between 5 and 12 per cent ever since the pandemic started. He also said that 66 per cent of government-sponsored health insurance schemes in the country are being run by the central government. He said when the COVID-19 pandemic started, a decision was made for sale of all medicines at the GST rate between 5 and 12 per cent and the GST rate for COVID-19 related medicines and instruments has been reduced to 5 per cent.

The minister said the GST rate for health insurance is 18 percent, which is as per international standards, and similar to what it was during pre-GST days in the country. He said senior citizens can avail tax rebate of up to Rs 1 lakh on health insurance policies. He said GST rates and exemptions on all services (including GST on health insurance premium) are prescribed on recommendations of the GST Council which is a constitutional body comprising Union Finance Minister and ministers as nominated by respective state and union territory governments.

He said at present, GST on health insurance services is levied at standard rate, i.e., 18 per cent. Specific health insurance schemes catering to the needs of economically weaker sections of the society and differently abled, such as Rashtriya Swasthya Bima Yojana (RSBY), Universal Health Insurance Scheme, Jan Argoya Bima Policy and Niramaya Health Insurance Scheme are fully exempt from GST. Further, he said, healthcare services are also exempt from the GST. Representations to reduce the GST on health insurance were placed before the GST Council in its 31st meeting held on December 22, 2018 and in its 37th meeting held on September 20, 2019.